Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapy. [PDF]
Rajendra E +26 more
europepmc +1 more source
Allosteric control of the bacterial ClpC/ClpP protease and its hijacking by antibacterial peptides. [PDF]
Jenne T +13 more
europepmc +1 more source
ADP-ribosylation: An emerging regulator of the epigenome. [PDF]
Camacho CV, Liu C, Kraus WL.
europepmc +1 more source
Mechanisms of PARP Inhibitor Resistance: From Replication Gap Biology and Transcription-Replication Conflicts to PROTAC-Based Next-Generation Strategies. [PDF]
Abinawanto, Sophian A.
europepmc +1 more source
PARP enzyme synthesis of protein-free poly(ADP-ribose): Implications for DNA damage signaling and repair. [PDF]
Langelier MF, Pascal JM.
europepmc +1 more source
Synaptic potentiation requires PARP1 activation: prevailing concepts are revisited. [PDF]
Cohen-Armon M, Segal M.
europepmc +1 more source
Menthol's disruptive effects on kanamycin-resistant Escherichia coli energy metabolism and ion fluxes. [PDF]
Tadevosyan S +5 more
europepmc +1 more source
PARP1 as a novel therapeutic and diagnostic tool in autoimmune rheumatic diseases: a systematic literature review. [PDF]
Dey M, Dey M.
europepmc +1 more source
PARG Mutation Uncovers Critical Structural Determinant for Poly(ADP-Ribose) Hydrolysis and Chromatin Regulation in Embryonic Stem Cells. [PDF]
Karpova Y, Piatz S, Bordet G, Tulin AV.
europepmc +1 more source

